Vote Nami Therapeutics
Nami Therapeutics Corp.
City/Town where Organization Located
Company/organization description (<500 characters)
Nami Therapeutics Corporation (Nami), incorporated in 2018, is a startup that is developing specifically designed nanoparticles for targeted drug delivery. Based on nanotechnologies invented by the co-founders at UConn and UNC, Nami is currently advancing a tumor-specific radioactive therapy to target peritoneal metastasis of ovarian cancer. Nami’s mission is to bring patients another chance to live a cancer-free life after they have exhausted conventional treatment options. In other words: Nano therapies, mega results.
Tell us about the milestones your venture accomplished in 2019, eg., key team members added, revenue level achieved, major sales made or endorsements received, successful exit, etc... (<500 characters)
Nami’s technology has been continuously supported grants from the National Institutes of Health and the American Cancer Society. In 2019, Nami was awarded a grant from the NIH National Cancer Institute’s highly competitive Phase 1 Small Business Technology Transfer (STTR) program. In this funding round, only 13% of submitted applications were successful in receiving funding to commercialize promising technologies. The grant, which will hopefully be followed by a much larger Phase 2 grant, is supporting translational efforts for moving the promising radiotherapeutic nanoparticle technology forward to clinical trials. This is a key milestone toward future commercialization.
Stage: Does your venture generate revenue? YES or NO
What CT entrepreneur ecosystem resources (spaces, programs, events, schools, etc.) have helped you succeed? (<500 characters)
Nami is located at UConn’s Technology Incubation Program (TIP), which provides mentoring, networking opportunities, and a variety of resources benefiting startup companies. Nami has received entrepreneurial training and seed funding from UConn’s NSF I-Corps Site, Accelerate UConn, and the Connecticut Center for Entrepreneurship and Innovation. These opportunities helped the team strengthen core competencies and further develop into a more solid business.
What people are saying about Nami Therapeutics ...
Nami Therapeutics Corp (’Nami’) is a startup company based in Storrs, CT and currently in the Technology Incubation Program at the University of Connecticut. Nami is developing specifically designed nanoparticles for the targeted delivery of therapeutic agents, including radio-therapeutics, to tumors. Nami (which mean ‘nano’ in Mandarin) is using technologies licensed from the University of Connecticut and the University of North Carolina. Nami aims to advance it nanotechnology-based products to the clinical trial stage by demonstrating the efficacy of its products in preclinical models, and by completing IND enabling activities such as manufacturing process development (CMC) and safety/toxicity assessments. Nami has gained significant traction in 2019, including participating in CCEI's Summer Fellowship Program, selected as a finalist for the Wolff New Venture Competition and receiving an STTR grant. Jennifer Murphy